You own any ?

I came across a concept called the Helsinki Bus Station Theory and it resonated with the pschology of investing for me. Here's the idea: every bus leaving Helsinki follows the same route for the first few stops. Then — and only then — the lines diverge. Bus 33 goes north. Bus 19 heads southwest. What looked identical at the start leads to completely different destinations. It was applied it to creative careers. I immediately saw it in investing strategy. 🚌 The early years of your strategy feel identical to everyone else's. Your QQQ and SPY look the same as your neighbour's. Your covered calls feel boring. Your TFSA contributions seem small. 🚌 So you get restless. You hear about something exciting. You hop off the bus and head back to the station to try a new line. - I am so guilty of this! 🚌 But the divergence was coming. You just didn't stay long enough to see it. The investors who build real wealth aren't smarter than you. They just stayed on the bus — the same disciplined, boring, blue chip strategy — long enough for the compounding math to separate them from everyone else. The bus you chose is already heading somewhere great. The question isn't which bus. It's whether you're still on it in year 10. I've had moments where I wanted to jump off. Sticking with the strategy changed everything. What's the hardest part of staying disciplined with your long-term strategy? https://jamesclear.com/stay-on-the-bus

Becomes compelling after losing about 50% from the peak.

I checked prior discussions on MRK and PFE before posting. We’ve covered both Pfizer and Merck extensively since 2023 across various threads, and a new post in those would likely get buried or lack context. MRK and PFE report earnings this week and next, respectively. Both stocks have been climbing steadily, mirroring gains in XLV (Health Care Select Sector SPDR Fund) and XBI (SPDR S&P Biotech ETF). It seems they’re finally attracting buyers. Both companies face a common challenge: patent expirations. To address this, they’re actively acquiring other firms to bolster their pipelines. I’m looking forward to their earnings reports. Thoughts on their outlook or recent moves?

Sahil Bloom shared something this week that hit me. Researchers at Yale found that people consistently overestimate how well they understand everyday things — a zipper, a toilet flush, a bicycle. Confidence scores were sevens. Write it out step by step? They collapsed to twos. He calls it the Illusion of Explanatory Depth. I think it's one of the most underrated traps in retirement planning. Most of us picked a number — $1M, $2M, $5K/month in passive income — through a kind of cultural osmosis. We heard it somewhere, it sounded right, and we filed it away as the goal. But when did we last actually defend that number? Here's the test I ran on myself: → Write down your retirement target → Then write what that number actually buys you — month by month, in specific dollars → Then ask: does this match the life I actually want to live? The first time I did this, I found my number was built on assumptions I'd never questioned. Generic lifestyle costs. A vague sense of "enough." Nothing tied to my real expenses or the income streams I'm actually building. @Eric Seto talks about this in the accelerator — the difference between having a number and having a plan. They're not the same thing. A retirement number is a wish. A plan is a thesis you can defend. What's your current target — and can you name one specific thing that number pays for in your ideal month? Drop it below 👇